Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is O  [Clear All Filters]
Journal Article
Gallego-Perez, D., Chang, L., Shi, J., Ma, J., Kim, S.-H., Zhao, X., Malkoc, V., Wang, X., Minata, M., Kwak, K.Joo, et al. (2016). On-chip clonal analysis of glioma stem cell motility and therapy resistance.Nano Lett.
Akagi, T., Kato, K., Kobayashi, M., Kosaka, N., Ochiya, T., and Ichiki, T. (2015). On-Chip Immunoelectrophoresis of Extracellular Vesicles Released from Human Breast Cancer Cells.Plos One10, e0123603.
Del Gobbo, A., Vaira, V., Rocco, E.Guerini, Palleschi, A., Bulfamante, G., Ricca, D., Fiori, S., Bosari, S., and Ferrero, S. (2014). The Oncofetal Protein IMP3: A Useful Marker to Predict Poor Clinical Outcome in Neuroendocrine Tumors of the Lung.J Thorac Oncol.
Liu, T., and Shyh-Chang, N. (2019). Oncofetal SALL4 driven tumorigenesis is highly dependent on oxidative phosphorylation, revealing therapeutic opportunities.Gastroenterology.
Sotoca, A.M., Prange, K.H.M., Reijnders, B., Mandoli, A., Nguyen, L.N., Stunnenberg, H.G., and Martens, J.H.A. (2015). The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.Oncogene.
Liu, J., Han, Q., Peng, T., Peng, M., Wei, B., Li, D., Wang, X., Yu, S., Yang, J., Cao, S., et al. (2015). The oncogene c-Jun impedes somatic cell reprogramming.Nat Cell Biol.
You, B., Mercier, F., Assenat, E., Langlois-Jacques, C., Glehen, O., Soulé, J., Payen, L., Kepenekian, V., Dupuy, M., Belouin, F., et al. (2019). The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients.Ebiomedicine51, 102574.
Rapin, N., and Porse, B.T. (2014). Oncogenic fusion proteins expressed in immature hematopoietic cells fail to recapitulate the transcriptional changes observed in human AML.Oncogenesis3, e106.
He, F., Melamed, J., Tang, M.-S., Huang, C., and Wu, X.-R. (2015). Oncogenic HRAS activates epithelial-mesenchyme transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas.Cancer Res.
Shetzer, Y., Molchadsky, A., and Rotter, V. (2016). Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Cold Spring Harb Perspect Med.
Wang, T., Li, C., Xia, C., Dong, Y., Yang, D., Geng, Y., Cai, J., Zhang, J., Zhang, X., and Wang, J. (2015). Oncogenic NRAS hyper-activates multiple pathways in human cord blood stem/progenitor cells and promotes myelomonocytic proliferation in vivo.Am J Transl Res7, 1963-73.
Dellambra, E. (2016). Oncogenic ras: A double-edged sword for human epidermal stem and transient amplifying cells.Small Gtpases.
Sun, J., Shen, Q., Lu, H., Jiang, Z., Xu, W., Feng, L., Li, L., Wang, X., Cai, X., and Jin, H. (2015). Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.Oncotarget.
Choi, D., Spinelli, C., Montermini, L., and Rak, J. (2018). Oncogenic Regulation Of Extracellular Vesicle Proteome And Heterogeneity.Proteomicse1800169.
Lipsey, C.C., Harbuzariu, A., Daley-Brown, D., and Gonzalez-Perez, R.R. (2016). Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.World J Methodol6, 43-55.
Shu, W., Liu, G., Dai, Y., Feng, A., Chen, Z., Han, J., and Li, X. (2019). The oncogenic role of NKAP in the growth and invasion of colon cancer cells.Oncol Rep.
Li, Z., Wang, Y., Yuan, C., Zhu, Y., Qiu, J., Zhang, W., Qi, B., Wu, H., Ye, J., Jiang, H., et al. (2014). Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer.Lab Invest.
Nadeau, S., An, W., Palermo, N., Feng, D., Ahmad, G., Dong, L., Borgstahl, G.E.O., Natarajan, A., Naramura, M., Band, V., et al. (2012). Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.Biochem Anal BiochemSuppl 6.
Miranda, A., Funes, J.M., Sánchez, N., Limia, C.M., Mesa, M., Quezada, S., Perez, R., and de León, J. (2015). Oncogenic transformation can orchestrate immune evasion and inflammation in human mesenchymal stem cells independently of extrinsic immune-selective pressure.Cancer Res.
Li, S., Zhou, J., Wu, H., Lu, Q., Tai, Y., Liu, Q., and Wang, C. (2018). Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells.Cell Cycle.
Sarkar, R.Radhikapra (2013). Oncologic profile of maxillary odontogenic myxoma: A rare case.Contemp Clin Dent4, 374-377.
Charvet, H.J., Orbay, H., Wong, M.S., and Sahar, D.E. (2015). The Oncologic Safety of Breast Fat Grafting and Contradictions Between Basic Science and Clinical Studies: A Systematic Review of the Recent Literature.Ann Plast Surg75, 471-479.
Putora, P.Martin, Baudis, M., Beadle, B.M., Naqa, I.El, Giordano, F.A., and Nicolay, N.H. (2020). Oncology Informatics: Status Quo and Outlook.Oncology1-3.
Ulasov, I.V., Borovjagin, A.V., Schroeder, B.A., and Baryshnikov, A.Y. (2014). Oncolytic adenoviruses: A thorny path to glioma cure.Genes Dis1, 214-226.
Lal, S., Carrera, D., Phillips, J.J., Weiss, W.A., and Raffel, C. (2018). An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.Neuro Oncol.